1-16 of 16
Wei Guo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fibroblast Activation Protein-Targeted Radioligand Therapy with 177Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study

Hao Fu, Jingxiong Huang, Tianzhi Zhao, Hongjian Wang, Yuhang Chen, Weizhi Xu, Yizhen Pang, Wei Guo, Long Sun, Hua Wu, Pengfei Xu, Bishan Su, Jingjing Zhang, Xiaoyuan Chen, Haojun Chen
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (23): 4740–4750.
https://doi.org/10.1158/1078-0432.CCR-23-1983
Published: 01 December 2023
View article titled, Fibroblast Activation Protein-Targeted Radioligand Therapy with <sup>177</sup>Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study
Open the PDF for Fibroblast Activation Protein-Targeted Radioligand Therapy with <sup>177</sup>Lu-EB-FAPI for Metastatic Radioiodine-Refractory Thyroid Cancer: First-in-Human, Dose-Escalation Study in another window
Includes: Supplementary data
Journal Articles

Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial

Jie Xu, Lu Xie, Xin Sun, Kuisheng Liu, Xin Liang, Zhenyu Cai, Xiaodong Tang, Wei Guo
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (6): 1040–1046.
https://doi.org/10.1158/1078-0432.CCR-22-3546
Published: 14 March 2023
View article titled, Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial
Open the PDF for Longer versus Shorter Schedules of Vincristine, Irinotecan, and Temozolomide (VIT) for Relapsed or Refractory Ewing Sarcoma: A Randomized Controlled Phase 2 Trial in another window
Includes: Supplementary data
Journal Articles

Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma

Jun Wang, Wei Guo, Xiaofang Wang, Xiaodong Tang, Xin Sun, Tingting Ren
Journal: Clinical Cancer Research
Clin Cancer Res (2023) 29 (3): 659–666.
https://doi.org/10.1158/1078-0432.CCR-22-2682
Published: 01 February 2023
View article titled, Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma
Open the PDF for Circulating Exosomal PD-L1 at Initial Diagnosis Predicts Outcome and Survival of Patients with Osteosarcoma in another window
Includes: Supplementary data
Journal Articles

Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma

Jiayong Liu, Tian Gao, Zhichao Tan, Shu Li, Jie Xu, Chujie Bai, Ruifeng Xue, Lu Xie, Lu Zhang, Zhengfu Fan, Wei Guo
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (16): 3473–3479.
https://doi.org/10.1158/1078-0432.CCR-22-0871
Published: 15 August 2022
View article titled, Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma
Open the PDF for Phase II Study of TQB2450, a Novel PD-L1 Antibody, in Combination with Anlotinib in Patients with Locally Advanced or Metastatic Soft Tissue Sarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract B12: Acetate metabolism mediated by acetyl-CoA synthetase 2 in cisplatin-resistant bladder cancer

He Wen, Sujin Lee, Wei-Guo Zhu, Ok-Jun Lee, Seok Joong Yun, Jayoung Kim, Sunghyouk Park
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (15_Supplement): B12.
https://doi.org/10.1158/1557-3265.BLADDER19-B12
Published: 03 August 2020
View article titled, Abstract B12: Acetate metabolism mediated by acetyl-CoA synthetase 2 in cisplatin-resistant bladder cancer
Journal Articles

Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells

Fiona Simpkins, Kibeom Jang, Hyunho Yoon, Karina E. Hew, Minsoon Kim, Diana J. Azzam, Jun Sun, Dekuang Zhao, Tan A. Ince, Wenbin Liu, Wei Guo, Zhi Wei, Gao Zhang, Gordon B. Mills, Joyce M. Slingerland
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (19): 4874–4886.
https://doi.org/10.1158/1078-0432.CCR-17-3697
Published: 01 October 2018
View article titled, Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells
Open the PDF for Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma

Wei Guo, Yun-Fan Sun, Min-Na Shen, Xiao-Lu Ma, Jiong Wu, Chun-Yan Zhang, Yan Zhou, Yang Xu, Bo Hu, Min Zhang, Gang Wang, Wei-Qin Chen, Lin Guo, Ren-Quan Lu, Chao-Hui Zhou, Xin Zhang, Ying-Hong Shi, Shuang-jian Qiu, Bai-shen Pan, Ya Cao, Jian Zhou, Xin-Rong Yang, Jia Fan
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (9): 2203–2213.
https://doi.org/10.1158/1078-0432.CCR-17-1753
Published: 30 April 2018
View article titled, Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma
Open the PDF for Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma

Yun-Fan Sun, Wei Guo, Yang Xu, Yin-Hong Shi, Zi-Jun Gong, Yuan Ji, Min Du, Xin Zhang, Bo Hu, Ao Huang, George G. Chen, Paul B.S. Lai, Ya Cao, Shuang-Jian Qiu, Jian Zhou, Xin-Rong Yang, Jia Fan
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (3): 547–559.
https://doi.org/10.1158/1078-0432.CCR-17-1063
Published: 31 January 2018
View article titled, Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma
Open the PDF for Circulating Tumor Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Loss of ARID1A Activates ANXA1, which Serves as a Predictive Biomarker for Trastuzumab Resistance

Katrien Berns, Amir Sonnenblick, Annemiek Gennissen, Sylvain Brohée, E. Marielle Hijmans, Bastiaan Evers, Debora Fumagalli, Christine Desmedt, Sibylle Loibl, Carsten Denkert, Patrick Neven, Wei Guo, Fan Zhang, Theo A. Knijnenburg, Tjalling Bosse, Michiel S. van der Heijden, Sanne Hindriksen, Wouter Nijkamp, Lodewyk F.A. Wessels, Heikki Joensuu, Gordon B. Mills, Roderick L. Beijersbergen, Christos Sotiriou, René Bernards
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (21): 5238–5248.
https://doi.org/10.1158/1078-0432.CCR-15-2996
Published: 31 October 2016
View article titled, Loss of <em>ARID1A</em> Activates <em>ANXA1</em>, which Serves as a Predictive Biomarker for Trastuzumab Resistance
Open the PDF for Loss of <em>ARID1A</em> Activates <em>ANXA1</em>, which Serves as a Predictive Biomarker for Trastuzumab Resistance in another window
Includes: Supplementary data
Journal Articles

Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma

Bo Hu, Xin-Rong Yang, Yang Xu, Yun-Fan Sun, Chao Sun, Wei Guo, Xin Zhang, Wei-Min Wang, Shuang-Jian Qiu, Jian Zhou, Jia Fan
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (23): 6212–6222.
https://doi.org/10.1158/1078-0432.CCR-14-0442
Published: 30 November 2014
View article titled, Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
Open the PDF for Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

Clinical Significance of EpCAM mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR–Based Platform

Wei Guo, Xin-Rong Yang, Yun-Fan Sun, Min-Na Shen, Xiao-Lu Ma, Jiong Wu, Chun-Yan Zhang, Yan Zhou, Yang Xu, Bo Hu, Xin Zhang, Jian Zhou, Jia Fan
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (18): 4794–4805.
https://doi.org/10.1158/1078-0432.CCR-14-0251
Published: 14 September 2014
View article titled, Clinical Significance of <em>EpCAM</em> mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR–Based Platform
Open the PDF for Clinical Significance of <em>EpCAM</em> mRNA-Positive Circulating Tumor Cells in Hepatocellular Carcinoma by an Optimized Negative Enrichment and qRT-PCR–Based Platform in another window
Includes: Supplementary data
Journal Articles

A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer

Mark A. Socinski, Jonathan Goldman, Iman El-Hariry, Marianna Koczywas, Vojo Vukovic, Leora Horn, Eugene Paschold, Ravi Salgia, Howard West, Lecia V. Sequist, Philip Bonomi, Julie Brahmer, Lin-Chi Chen, Alan Sandler, Chandra P. Belani, Timothy Webb, Harry Harper, Mark Huberman, Suresh Ramalingam, Kwok-Kin Wong, Florentina Teofilovici, Wei Guo, Geoffrey I. Shapiro
Journal: Clinical Cancer Research
Clin Cancer Res (2013) 19 (11): 3068–3077.
https://doi.org/10.1158/1078-0432.CCR-12-3381
Published: 30 May 2013
View article titled, A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer
Open the PDF for A Multicenter Phase II Study of Ganetespib Monotherapy in Patients with Genotypically Defined Advanced Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis

Ai-Lan Cheng, Wei-Guo Huang, Zhu-Chu Chen, Fang Peng, Peng-Fei Zhang, Mao-Yu Li, Feng Li, Jian-Ling Li, Cui Li, Hong Yi, Bin Yi, Zhi-Qiang Xiao
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (2): 435–445.
https://doi.org/10.1158/1078-0432.CCR-07-1215
Published: 25 January 2008
View article titled, Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis
Open the PDF for Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis in another window
Journal Articles

Eliminating Established Tumor in nu/nu Nude Mice by a Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand–Armed Oncolytic Adenovirus

Fengqin Dong, Li Wang, John J. Davis, Wenxian Hu, Lidong Zhang, Wei Guo, Fuminori Teraishi, Lin Ji, Bingliang Fang
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (17): 5224–5230.
https://doi.org/10.1158/1078-0432.CCR-06-0244
Published: 01 September 2006
View article titled, Eliminating Established Tumor in nu/nu Nude Mice by a Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand–Armed Oncolytic Adenovirus
Open the PDF for Eliminating Established Tumor in nu/nu Nude Mice by a Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand–Armed Oncolytic Adenovirus in another window
Journal Articles

C-CAM1, a Candidate Tumor Suppressor Gene, Is Abnormally Expressed in Primary Lung Cancers

Luo Wang, Sue Hwa Lin, Wei Guo Wu, Bonnie L. Kemp, Garrett L. Walsh, Waun Ki Hong, Li Mao
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (8): 2988–2993.
Published: 01 August 2000
View article titled, <em>C-CAM1</em>, a Candidate Tumor Suppressor Gene, Is Abnormally Expressed in Primary Lung Cancers
Open the PDF for <em>C-CAM1</em>, a Candidate Tumor Suppressor Gene, Is Abnormally Expressed in Primary Lung Cancers in another window
Journal Articles

Mechanisms of Methotrexate Resistance in Osteosarcoma

Wei Guo, John H. Healey, Paul A. Meyers, Marc Ladanyi, Andrew G. Huvos, Joseph R. Bertino, Richard Gorlick
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (3): 621–627.
Published: 01 March 1999
View article titled, Mechanisms of Methotrexate Resistance in Osteosarcoma
Open the PDF for Mechanisms of Methotrexate Resistance in Osteosarcoma in another window